Volume | 54,781 |
|
|||||
News | - | ||||||
Day High | 2.84 | Low High |
|||||
Day Low | 2.56 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
TFF Pharmaceuticals Inc | TFFP | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
2.81 | 2.56 | 2.84 | 2.73 | 2.71 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
255 | 54,781 | US$ 2.72 | US$ 148,805 | - | 2.51 - 21.2475 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
15:00:00 | 1,000 | US$ 2.7499 | USD |
TFF Pharmaceuticals Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
6.5M | 2.37M | - | 734k | -21.24M | -8.98 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
TFF Pharmaceuticals News
Date | Time | Source | News Article |
---|---|---|---|
12/19/2023 | 05:07 | Edgar (US Regulatory) | Form 8-K - Current report |
12/15/2023 | 15:06 | Edgar (US Regulatory) | Form 8-K - Current report |
12/12/2023 | 23:15 | Edgar (US Regulatory) | Form EFFECT - Notice of Effectiveness |
12/08/2023 | 15:52 | Edgar (US Regulatory) | Form S-3/A - Registration statement under Securities Act of.. |
12/08/2023 | 15:10 | Edgar (US Regulatory) | Form 8-K - Current report |
12/04/2023 | 16:28 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
12/04/2023 | 16:26 | Edgar (US Regulatory) | Form 8-K - Current report |
11/22/2023 | 16:14 | Edgar (US Regulatory) | Form 8-K - Current report |
11/21/2023 | 15:41 | Edgar (US Regulatory) | Form S-3 - Registration statement under Securities Act of.. |
11/14/2023 | 15:06 | Edgar (US Regulatory) | Form 8-K - Current report |
10/04/2023 | 15:07 | Edgar (US Regulatory) | Form DEF 14A - Other definitive proxy statements |
10/04/2023 | 15:07 | Edgar (US Regulatory) | Form DEFA14A - Additional definitive proxy soliciting.. |
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical TFFP Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 2.57 | 3.1752 | 2.5445 | 2.91 | 34,466 | 0.16 | 6.23% |
1 Month | 6.01 | 6.336 | 2.51 | 3.87 | 35,712 | -3.28 | -54.58% |
3 Months | 5.96 | 11.00 | 2.51 | 6.08 | 34,288 | -3.23 | -54.19% |
6 Months | 7.50 | 11.00 | 2.51 | 7.12 | 100,295 | -4.77 | -63.60% |
1 Year | 15.25 | 21.2475 | 2.51 | 9.42 | 125,223 | -12.52 | -82.10% |
3 Years | 283.00 | 307.00 | 2.51 | 99.64 | 152,295 | -280.27 | -99.04% |
5 Years | 125.75 | 528.50 | 2.51 | 197.05 | 178,527 | -123.02 | -97.83% |
TFF Pharmaceuticals Description
TFF Pharmaceuticals Inc is a biopharmaceutical company focused on developing and commercializing drug products based on its patented Thin Film Freezing, or TFF, technology platform. It is focused on the development of inhaled dry powder drugs for the treatment of pulmonary diseases and conditions. |